As per reporter's narrative: thor study.Clinical trial thor_torontogeneral patient number (b)(6), a female patient of 77 years old had relevant medical condition of thoracic aneurysm, coronary artery disease, copd, diabetes (type unknown), history of stroke and taking antiplatelets (asa81) prior to procedure.Former smoker and asa grade 4.The events were related to the device failure/ deficiency but not related to procedure or pre-existing condition and surgical intervention was required.On the post-operative day 6/7, patient developed left lower extremity coolness, pain and tingling and loss of left dorsalis pedalis/posterior tibialis pulses.Ct revealed an embolus of the left common femoral artery and a right common femoral artery pseudoaneurysm.Patient was started on iv heparin and taken to or by vascular surgery for surgical intervention.Left common femoral artery embolectomy and right common femoral artery pseudoaneurysm was repaired.Additional information received from site on 23 aug 23 confirmed this event was not device related.Site also confirmed unfortunately they are unable to provide batch details for this event.This report has been submitted as initial/ final for mfg.Report fda 9612515-2023-00013.
|